Individual estimation of the level of prostatic specific antigen in patients with prostate cancer after brachytherapy

by N. G. Minayeva, P. V. Sviridov, O. B. Karyakin, Ye. M. Parshov
Published 2020-02-01

HORMONE AND RADIATION THERAPY IN HIGH- AND VERY HIGH-RISK PATIENTS WITH PROSTATE CANCER

by A. O. Karyakin, Yu. V. Gumenetskaya, N. A. Gorban, N. G. Minayeva, O. B. Karyakin
Published 2014-08-01

HORMONE AND RADIATION THERAPY IN HIGH- AND VERY HIGH-RISK PATIENTS WITH PROSTATE CANCER

by A. O. Karyakin, Yu. V. Gumenetskaya, N. A. Gorban, N. G. Minayeva, O. B. Karyakin
Published 2014-08-01

Zometa in therapy for bone metastases of prostate cancer during androgenic deprivation (Results of Russian multicenter study)

by O. B. Karyakin, B. P. Matveev, V. B. Matveev, I. G. Rusakov, O. B. Loran, Ye. I. Veliyev, L. V. Shaplygin, B. V. Bukharkin, V. A. Biryukov, N. G. Minayeva, A. A. Atayev, V. M. Shelepova, M. I. Karelin, D. G. Prokhorov, Yu. N. Khrizman, V. K. Shakurov, E. F. Abdrakhmanov, V. N. Zhuravlev, A. V. Zyryanov, V. O. Mager, P. A. Karnaukh
Published 2020-03-01